Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...

CHICAGO--(BUSINESS WIRE)--Ultrasound contrast agents show promise for detecting and evaluating uterine disorders and prostate cancers, scientists reported today at the annual Advances in Contrast ...

Researchers from the University of Washington School of Medicine in Seattle, Mayo Clinic in Rochester, Minn., the University ...

Nanomedicine. 2015;10(2):321-341. Delivery: "Go where we want." The contrast agent must be able to be delivered in vivo and transported to the site of interest. Nontoxic: "Do no harm along the way." ...

The recommendation is included in the organization’s “Guidelines for the management of chronic coronary syndromes,” published Aug. 30 in the European Heart Journal. “Ultrasound contrast agents ...

BR55 was safe and highly accurate (>95%) at marking VEGFR2 expression in patients with breast, ovarian and thyroid cancer, as well as Crohn disease. The Food and Drug Administration (FDA) has granted ...

Simulations by Rice University engineers have revealed details about the molecular interactions between gadolinium contrast agents used in MRI scans and their liquid environment. In this model, green ...

A new study has found why MRI scans may leave harmful metals behind in a person's body. The University of New Mexico (UNM) study explored health risks caused by toxic rare earth metal gadolinium, ...